卵巢高级别浆液性腺癌的癌基因。

Q2 Biochemistry, Genetics and Molecular Biology
Genes and Cancer Pub Date : 2020-11-11 eCollection Date: 2020-12-31 DOI:10.18632/genesandcancer.206
Pacharla Manasa, Chirukandath Sidhanth, Syama Krishnapriya, Sekar Vasudevan, Trivadi S Ganesan
{"title":"卵巢高级别浆液性腺癌的癌基因。","authors":"Pacharla Manasa,&nbsp;Chirukandath Sidhanth,&nbsp;Syama Krishnapriya,&nbsp;Sekar Vasudevan,&nbsp;Trivadi S Ganesan","doi":"10.18632/genesandcancer.206","DOIUrl":null,"url":null,"abstract":"<p><p>High grade serous ovarian cancer is characterized by relatively few mutations occurring at low frequency, except in TP53. However other genetic aberrations such as copy number variation alter numerous oncogenes and tumor suppressor genes. Oncogenes are positive regulators of tumorigenesis and play a critical role in cancer cell growth, proliferation, and survival. Accumulating evidence suggests that they are crucial for the development and the progression of high grade serous ovarian carcinoma (HGSOC). Though many oncogenes have been identified, no successful inhibitors targeting these molecules and their associated pathways are available. This review discusses oncogenes that have been identified recently in HGSOC using different screening strategies. All the genes discussed in this review have been functionally characterized both <i>in vitro</i> and <i>in vivo</i> and some of them are able to transform immortalized ovarian surface epithelial and fallopian tube cells upon overexpression. However, it is necessary to delineate the molecular pathways affected by these oncogenes for the development of therapeutic strategies.</p>","PeriodicalId":38987,"journal":{"name":"Genes and Cancer","volume":"11 3-4","pages":"122-136"},"PeriodicalIF":0.0000,"publicationDate":"2020-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805537/pdf/","citationCount":"2","resultStr":"{\"title\":\"Oncogenes in high grade serous adenocarcinoma of the ovary.\",\"authors\":\"Pacharla Manasa,&nbsp;Chirukandath Sidhanth,&nbsp;Syama Krishnapriya,&nbsp;Sekar Vasudevan,&nbsp;Trivadi S Ganesan\",\"doi\":\"10.18632/genesandcancer.206\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>High grade serous ovarian cancer is characterized by relatively few mutations occurring at low frequency, except in TP53. However other genetic aberrations such as copy number variation alter numerous oncogenes and tumor suppressor genes. Oncogenes are positive regulators of tumorigenesis and play a critical role in cancer cell growth, proliferation, and survival. Accumulating evidence suggests that they are crucial for the development and the progression of high grade serous ovarian carcinoma (HGSOC). Though many oncogenes have been identified, no successful inhibitors targeting these molecules and their associated pathways are available. This review discusses oncogenes that have been identified recently in HGSOC using different screening strategies. All the genes discussed in this review have been functionally characterized both <i>in vitro</i> and <i>in vivo</i> and some of them are able to transform immortalized ovarian surface epithelial and fallopian tube cells upon overexpression. However, it is necessary to delineate the molecular pathways affected by these oncogenes for the development of therapeutic strategies.</p>\",\"PeriodicalId\":38987,\"journal\":{\"name\":\"Genes and Cancer\",\"volume\":\"11 3-4\",\"pages\":\"122-136\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-11-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7805537/pdf/\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Genes and Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.18632/genesandcancer.206\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2020/12/31 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Biochemistry, Genetics and Molecular Biology\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Genes and Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18632/genesandcancer.206","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/12/31 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 2

摘要

高级别浆液性卵巢癌的特点是相对较少的突变发生在低频率,除了TP53。然而,其他遗传畸变,如拷贝数变异,改变了许多致癌基因和肿瘤抑制基因。癌基因是肿瘤发生的积极调节因子,在癌细胞的生长、增殖和存活中起着关键作用。越来越多的证据表明,它们对高级别浆液性卵巢癌(HGSOC)的发生和进展至关重要。虽然许多致癌基因已经被确定,但目前还没有针对这些分子及其相关途径的成功抑制剂。本文综述了近年来使用不同筛查策略在HGSOC中发现的致癌基因。本文讨论的所有基因都已经在体外和体内进行了功能表征,其中一些基因能够通过过表达转化永生化的卵巢表面上皮细胞和输卵管细胞。然而,有必要描绘受这些致癌基因影响的分子途径,以制定治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Oncogenes in high grade serous adenocarcinoma of the ovary.

Oncogenes in high grade serous adenocarcinoma of the ovary.

Oncogenes in high grade serous adenocarcinoma of the ovary.

High grade serous ovarian cancer is characterized by relatively few mutations occurring at low frequency, except in TP53. However other genetic aberrations such as copy number variation alter numerous oncogenes and tumor suppressor genes. Oncogenes are positive regulators of tumorigenesis and play a critical role in cancer cell growth, proliferation, and survival. Accumulating evidence suggests that they are crucial for the development and the progression of high grade serous ovarian carcinoma (HGSOC). Though many oncogenes have been identified, no successful inhibitors targeting these molecules and their associated pathways are available. This review discusses oncogenes that have been identified recently in HGSOC using different screening strategies. All the genes discussed in this review have been functionally characterized both in vitro and in vivo and some of them are able to transform immortalized ovarian surface epithelial and fallopian tube cells upon overexpression. However, it is necessary to delineate the molecular pathways affected by these oncogenes for the development of therapeutic strategies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Genes and Cancer
Genes and Cancer Biochemistry, Genetics and Molecular Biology-Genetics
CiteScore
3.90
自引率
0.00%
发文量
6
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信